Literature DB >> 26493994

PKM2 promotes stemness of breast cancer cell by through Wnt/β-catenin pathway.

Zheng Zhao1,2, Zhangjun Song3, Zijun Liao2, Zhigang Liu2, Haifeng Sun2, Baoxia Lei2, Wenjuan Chen2, Chengxue Dang4.   

Abstract

Metastasis is one of the main causes of breast cancer (BCa)-related deaths in female. It has been reported that cancer stem cell played an important role in metastasis. Here we first revealed a specific role of pyruvate kinase isozymes M2 (PKM2) in the stemness of breast cancer cells. Breast cancer tissue analysis confirmed the upregulation of PKM2 in breast cancer, and high PKM2 levels were associated with poor prognosis of breast cancer patients. Holoclone assay and colony formation assay significantly elucidated the role of PKM2 in the self-renewal of breast cancer cells. Moreover, PKM2 elevated the proportion of stem cell and the ability of sphere formation in breast cancer cells. PKM2 played its functional role in stemness by regulating β-catenin. Collectively, we identified critical roles of PKM2 in the stemness of breast cancer cells which may elevate the therapeutic effect on breast cancer patients.

Entities:  

Keywords:  Cancer stem cell; Holoclone; Pyruvate kinase isozymes M2; Stemness; β-Catenin

Mesh:

Substances:

Year:  2015        PMID: 26493994     DOI: 10.1007/s13277-015-4121-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  35 in total

1.  Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts.

Authors:  Juntao Lang; Xiaoli Lan; Yu Liu; Xueyan Jin; Tao Wu; Xun Sun; Qiong Wen; Rui An
Journal:  Nucl Med Biol       Date:  2015-01-09       Impact factor: 2.408

Review 2.  Cancer stem cells: mirage or reality?

Authors:  Piyush B Gupta; Christine L Chaffer; Robert A Weinberg
Journal:  Nat Med       Date:  2009-09-04       Impact factor: 53.440

Review 3.  Wnt/β-catenin signaling in embryonic stem cell self-renewal and somatic cell reprogramming.

Authors:  Toshio Miki; Shin-ya Yasuda; Michael Kahn
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

Review 4.  Notch signaling in the regulation of stem cell self-renewal and differentiation.

Authors:  Jianing Liu; Chihiro Sato; Massimiliano Cerletti; Amy Wagers
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

Review 5.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

6.  Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block.

Authors:  Peggy Kirstetter; Kristina Anderson; Bo T Porse; Sten Eirik W Jacobsen; Claus Nerlov
Journal:  Nat Immunol       Date:  2006-09-03       Impact factor: 25.606

7.  Stromal niche cells protect early leukemic FLT3-ITD+ progenitor cells against first-generation FLT3 tyrosine kinase inhibitors.

Authors:  Amanda Parmar; Stefanie Marz; Sally Rushton; Christina Holzwarth; Katarina Lind; Sabine Kayser; Konstanze Döhner; Christian Peschel; Robert A J Oostendorp; Katharina S Götze
Journal:  Cancer Res       Date:  2011-05-05       Impact factor: 12.701

8.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

9.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

Review 10.  Wnt/catenin signaling in adult stem cell physiology and disease.

Authors:  Alexander Ring; Yong-Mi Kim; Michael Kahn
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

View more
  15 in total

Review 1.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

2.  Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma.

Authors:  Zheng-Xuan Liu; Liang Hong; Song-Qing Fang; Guang-Hua Tan; Pei-Guan Huang; Zhi Zeng; Xue Xia; Xiao-Xu Wang
Journal:  Tumour Biol       Date:  2016-09-19

Review 3.  Cancer stem cells: a major culprit of intra-tumor heterogeneity.

Authors:  Faiza Naz; Mengran Shi; Salvia Sajid; Zhao Yang; Changyuan Yu
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

4.  PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation.

Authors:  Le Zhang; Justine Bailleul; Taha Yazal; Kevin Dong; David Sung; Amy Dao; Laura Gosa; David Nathanson; Kruttika Bhat; Sara Duhachek-Muggy; Claudia Alli; Milana Bochkur Dratver; Frank Pajonk; Erina Vlashi
Journal:  Breast Cancer Res Treat       Date:  2019-08-01       Impact factor: 4.872

5.  MicroRNA 675 cooperates PKM2 to aggravate progression of human liver cancer stem cells induced from embryonic stem cells.

Authors:  Yuxin Yang; Qiuyu Meng; Chen Wang; Xiaonan Li; Yanan Lu; Xiaoru Xin; Qidi Zheng; Dongdong Lu
Journal:  J Mol Med (Berl)       Date:  2018-08-23       Impact factor: 4.599

6.  Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.

Authors:  Yiming Yang; Ke Wu; Yulin Liu; Liang Shi; Kaixiong Tao; Guobin Wang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

7.  Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer.

Authors:  Tai-Kuang Chao; Tien-Shuo Huang; Yu-Ping Liao; Rui-Lan Huang; Po-Hsuan Su; Hueng-Yuan Shen; Hung-Cheng Lai; Yu-Chi Wang
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

8.  Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.

Authors:  Qidi Zheng; Zhuojia Lin; Jie Xu; Yanan Lu; Qiuyu Meng; Chen Wang; Yuxin Yang; Xiaoru Xin; Xiaonan Li; Hu Pu; Xin Gui; Tianming Li; Wujun Xiong; Dongdong Lu
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

Review 9.  Signaling Pathways Induced by Leptin during Epithelial⁻Mesenchymal Transition in Breast Cancer.

Authors:  Monserrat Olea-Flores; Juan Carlos Juárez-Cruz; Miguel A Mendoza-Catalán; Teresita Padilla-Benavides; Napoleón Navarro-Tito
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

10.  Protein Stability of Pyruvate Kinase Isozyme M2 Is Mediated by HAUSP.

Authors:  Hae-Seul Choi; Chang-Zhu Pei; Jun-Hyeok Park; Soo-Yeon Kim; Seung-Yeon Song; Gyeong-Jin Shin; Kwang-Hyun Baek
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.